Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007406
Filing Date
2025-05-12
Accepted
2025-05-12 16:36:39
Documents
81
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20250331x10q.htm   iXBRL 10-Q 1293936
2 EX-31.1 irwd-20250331xex31d1.htm EX-31.1 16477
3 EX-31.2 irwd-20250331xex31d2.htm EX-31.2 16536
4 EX-32.1 irwd-20250331xex32d1.htm EX-32.1 7875
5 EX-32.2 irwd-20250331xex32d2.htm EX-32.2 8310
  Complete submission text file 0001558370-25-007406.txt   6693441

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20250331.xsd EX-101.SCH 61359
7 EX-101.CAL irwd-20250331_cal.xml EX-101.CAL 57860
8 EX-101.DEF irwd-20250331_def.xml EX-101.DEF 270138
9 EX-101.LAB irwd-20250331_lab.xml EX-101.LAB 472134
10 EX-101.PRE irwd-20250331_pre.xml EX-101.PRE 414224
84 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20250331x10q_htm.xml XML 945786
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 25935467
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)